Evidence map›Paper›PMID 40732332›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Exploring the Cardiovascular Safety Profile of Ibuprofen: Insights from EudraVigilance Database.

Cristina Anamaria Buciuman, Carmen Maximiliana Dobrea, Anca Butuca, Adina Frum, Felicia Gabriela Gligor, Octavia Gligor, Laura Grațiela Vicaș, Claudiu Morgovan

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cristina Anamaria BuciumanFaculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Str., 020956 Bucharest, Romania.
Carmen Maximiliana DobreaPreclinical Department, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 2A Lucian Blaga Str., 550169 Sibiu, Romania.ORCID 0000-0002-9913-1750
Anca ButucaPreclinical Department, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 2A Lucian Blaga Str., 550169 Sibiu, Romania.ORCID 0000-0003-1540-641X
Adina FrumPreclinical Department, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 2A Lucian Blaga Str., 550169 Sibiu, Romania.ORCID 0000-0003-4874-0430
Felicia Gabriela GligorPreclinical Department, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 2A Lucian Blaga Str., 550169 Sibiu, Romania.ORCID 0000-0003-3167-9864
Octavia GligorFaculty of Medicine and Pharmacy, University of Oradea, 10, 1 December Square, 410073 Oradea, Romania.ORCID 0000-0002-6672-1535
Laura Grațiela VicașFaculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Str., 020956 Bucharest, Romania.ORCID 0000-0001-5328-333X
Claudiu MorgovanPreclinical Department, Faculty of Medicine, "Lucian Blaga" University of Sibiu, 2A Lucian Blaga Str., 550169 Sibiu, Romania.ORCID 0000-0003-2730-8729

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiovascular toxicitydisproportionality analysisEudraVigilanceibuprofen safetypharmacovigilance

Identifiers

PMID40732332
PMCPMC12300713

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.